Guatemala Medical Device Authority: MSPAS and DRCPFA Scope of Competence

1. Key takeaways

The competent authority for medical devices and in vitro diagnostics (IVDs) in Guatemala is the Department for the Regulation and Control of Pharmaceutical and Related Products (DRCPFA) under the Ministry of Public Health and Social Assistance (MSPAS). DRCPFA sits under the General Directorate of Health Regulation, Oversight and Control (DGRVCS), and every step of product health registration — acceptance of applications, technical review, issuance of certificates, amendments, renewals and cancellations — is handled end to end by this single office. The National Health Laboratory (LNS) carries out the physicochemical and microbiological testing required for Class II–IV products, while the Superintendence of Tax Administration (SAT) is responsible for import clearance and the collection of duties and taxes. In day-to-day practice a company therefore submits through one window only, but the full compliance chain actually spans four institutions. Understanding how these bodies divide their work is the first step to planning a Guatemalan project realistically, because delays almost always arise at the handover points between document review, laboratory testing and customs processing rather than inside any single office. In practical terms this means the applicant must manage three distinct dependencies at once: a regulatory file that satisfies DRCPFA, a sample that satisfies LNS, and import documentation that satisfies SAT, all pointing to the same registered product.

2. Legal basis

The regulatory framework that defines DRCPFA and its powers is layered from constitutional law down to technical standards, and each layer performs a distinct function: the Constitution establishes the State duty, the Health Code creates the registration obligation, the two Gubernativo Agreements assign the administrative competence, and Norma Técnica 37 operationalises the requirements for medical devices. The following table summarises each level, the governing instrument and the points most relevant to medical device registration.

DRCPFA address: Avenida Bolívar 28-07, Zona 8, Guatemala City; telephone 2231-2950; official website https://medicamentos.mspas.gob.gt/.

3. Expert insights

Insight one: the authority to issue technical standards derives from Article 35, not from an ad hoc ministerial delegation. The POR TANTO clauses of both NT-37 and NT-40 spell out the full chain of authorisation: Article 96 of the Constitution, then the relevant articles of the Health Code, then Article 35 of Agreement 115-99, then Article 4 of Agreement 712-99. This chain means DRCPFA can update technical standards without any legislative procedure, which in turn means the version numbers of technical standards will change more frequently than the underlying statutes. When scheduling a project, it is more effective to set up NT version re-verification as a standalone milestone than to monitor only statutory amendments.

Insight two: review and laboratory testing are separated, so the timeline must be split into two segments. DRCPFA is responsible for document review and LNS is responsible for sample testing, and the two offices do not share one schedule. Annex 1 of NT-37 makes clear that Class I products are not tested while Class II–IV products are, and a note to Annex 2 further provides that when the LNS result is nonconforming the registration is automatically cancelled. Treating certificate issuance and the test conclusion as a single event is the main source of production and launch planning errors, because a dossier can be approved on paper while the sample is still queued at the laboratory, and the registration remains conditional on that laboratory outcome.

Insight three: DRACES is not DRCPFA. Both acronyms sit within the MSPAS system, but DRACES regulates health establishments and facilities while DRCPFA regulates pharmaceuticals and related products. Enquiries or documents submitted to the wrong department will not be accepted at the window, and there is no proactive forwarding between them, so the file simply stalls until the applicant resubmits it to the correct office.

4. Practical recommendations

• Set the point of contact at DRCPFA when the project is initiated; foreign manufacturers do not submit directly and must act through a registration entity legally established in Guatemala.
• Build a document structure of one product, one master file, placing the classification rationale, the registration dossier, label versions and the records of amendments and renewals under the same index.
• For Class II–IV projects, schedule LNS testing as a separate workstream and do not run it on the same timeline as document review.
• Align with SAT requirements in advance for the import stage, and confirm that the sanitary registration number, the batch number and the outer packaging information match in all three places.
• Take the official position from the current texts published on medicamentos.mspas.gob.gt, not from industry second-hand accounts.

5. Verification checklist

• □ Confirm the competent authority is DRCPFA, reporting to DGRVCS, within MSPAS
• □ Record Article 96 of the Constitution and Articles 162, 182 and 183 of the Health Code
• □ Record the chain of authorisation between Article 35 of Agreement 115-99 and Article 4 of Agreement 712-99
• □ Distinguish the functional boundary between DRCPFA and DRACES
• □ Confirm whether the product requires LNS testing (determined per Annex 1 of NT-37)

Regulatory information verified as of 29 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Guatemalan market. Our team manages Ministry of Public Health and Social Assistance (MSPAS) registrations, coordinates import and distributor requirements, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com